SORT BY

FILTER BY

fastest growing stats

also on other fortune lists

100 Fastest-Growing Companies

Courtesy of Supernus Pharmaceauticals

3

Supernus Pharmaceuticals

SUPN

Supernus Pharmaceuticals is tackling what is, perhaps, the most difficult project in the life sciences sector—treating the diseases that afflict our brains, including epilepsy and migraines. In the second quarter of 2018, the firm’s revenues ballooned by more than 30% to $99.5 million, driven by greater sales of flagship drugs Oxtellar XR and Trokendi XR. The company’s latest earnings figures fell a bit short of Wall Street expectations, but that may not be of much concern given how hot the stock has been over the past five years: It has provided shareholders with a stunning 571% return.

Looking for leads, investment insights, or competitive intelligence?

Location

Rockville, Md.

Industry

Pharmaceuticals

Sector

Health Care

Current Streak

-

Years on List

1

CEO

Jack Khattar

Revenue and net income for the four quarters ended on or before April 30, 2018. Total return for the period ended June 29, 2018.
Revenue, Net Income
$ millions
Revenue past four quarters ($M)$335
Net Income past four quarters ($M)$73
Growth Rates and Ranks
Revenue 3 Yr Growth Rank19
Revenue 3 Yr Annual Growth Rate46%
EPS 3 Yr Growth Rank5
EPS 3 Yr Annual Growth Rate154%
Total Return 3 Yr Rank8
Total Return 3 Yr Annual Rate52%
Beat S&P 500 (11.9%)yes
P/E Ratio29
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a